PL356767A1 - Zastosowanie hormonów płciowych do wytwarzania donosowej kompozycji farmaceutycznej, korzystnej do leczenia niepożądanych krwawień z macicy - Google Patents

Zastosowanie hormonów płciowych do wytwarzania donosowej kompozycji farmaceutycznej, korzystnej do leczenia niepożądanych krwawień z macicy

Info

Publication number
PL356767A1
PL356767A1 PL00356767A PL35676700A PL356767A1 PL 356767 A1 PL356767 A1 PL 356767A1 PL 00356767 A PL00356767 A PL 00356767A PL 35676700 A PL35676700 A PL 35676700A PL 356767 A1 PL356767 A1 PL 356767A1
Authority
PL
Poland
Prior art keywords
beneficial
preparation
treatment
pharmaceutical composition
uterine bleeding
Prior art date
Application number
PL00356767A
Other languages
English (en)
Inventor
Yannis Tsounderos
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL356767A1 publication Critical patent/PL356767A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00356767A 1999-03-31 2000-03-30 Zastosowanie hormonów płciowych do wytwarzania donosowej kompozycji farmaceutycznej, korzystnej do leczenia niepożądanych krwawień z macicy PL356767A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904022A FR2791572A1 (fr) 1999-03-31 1999-03-31 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
PCT/FR2000/000790 WO2000059447A2 (fr) 1999-03-31 2000-03-30 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables

Publications (1)

Publication Number Publication Date
PL356767A1 true PL356767A1 (pl) 2004-07-12

Family

ID=9543854

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356767A PL356767A1 (pl) 1999-03-31 2000-03-30 Zastosowanie hormonów płciowych do wytwarzania donosowej kompozycji farmaceutycznej, korzystnej do leczenia niepożądanych krwawień z macicy

Country Status (16)

Country Link
EP (1) EP1143978A2 (pl)
JP (1) JP2002541076A (pl)
KR (1) KR20010102464A (pl)
CN (1) CN1346273A (pl)
AU (1) AU3662300A (pl)
BR (1) BR0008577A (pl)
CA (1) CA2361885A1 (pl)
EA (1) EA200100801A1 (pl)
FR (1) FR2791572A1 (pl)
HK (1) HK1044486A1 (pl)
HU (1) HUP0200244A3 (pl)
NO (1) NO20014022L (pl)
NZ (1) NZ513672A (pl)
PL (1) PL356767A1 (pl)
WO (1) WO2000059447A2 (pl)
ZA (1) ZA200106689B (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
JP4450435B2 (ja) * 1996-07-23 2010-04-14 フィーリン・ファーマシューティカルズ・インコーポレイテッド Ｐｍｓおよび不安の症状を緩和する、ｖｎｏにおける神経化学刺激物質としてのステロイド

Also Published As

Publication number Publication date
HUP0200244A3 (en) 2003-05-28
HK1044486A1 (zh) 2002-10-25
WO2000059447A3 (fr) 2001-04-26
BR0008577A (pt) 2002-10-01
EP1143978A2 (fr) 2001-10-17
KR20010102464A (ko) 2001-11-15
AU3662300A (en) 2000-10-23
HUP0200244A2 (hu) 2002-07-29
JP2002541076A (ja) 2002-12-03
CN1346273A (zh) 2002-04-24
NO20014022D0 (no) 2001-08-17
NO20014022L (no) 2001-08-17
WO2000059447A2 (fr) 2000-10-12
CA2361885A1 (fr) 2000-10-12
EA200100801A1 (ru) 2002-04-25
ZA200106689B (en) 2002-11-14
NZ513672A (en) 2001-09-28
FR2791572A1 (fr) 2000-10-06

Similar Documents

Publication Publication Date Title
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
HUP0401192A3 (en) Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
ATE491436T1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
LTPA2014019I1 (lt) Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20031273L (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
EE200300245A (et) Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
DK1764111T3 (da) Vaginalt indgivne anti-dysrytmi midler til behandling af uterin dysrytmi
BR0014560B1 (pt) uso de uma composiÇço de tratamento de tecidos.
DE60223576D1 (de) Hautbehandlungszusammensetzung
EE05308B1 (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
PL356767A1 (pl) Zastosowanie hormonów płciowych do wytwarzania donosowej kompozycji farmaceutycznej, korzystnej do leczenia niepożądanych krwawień z macicy
AU2001269439A1 (en) Medicinal preparations for treating sex hormone-dependent diseases
PT1373249E (pt) Derivados de imidazolidina, sua preparacao e sua utilizacao como agente anti-inflamatorio
DE60114448D1 (de) Imidazolonderivate zur behandlung viraler krankheiten
EP1304117A4 (en) MEDIUM FOR BONE DISEASES
ITMI20011379A0 (it) Procedimento per la preparazione del divalproato sodico
FI20011446L (fi) Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumus
DE60107973D1 (de) Gewebehandlungszubereitung

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)